When you start a medication like Dupixent (dupilumab), you expect relief from eczema or asthma, not the devastation of a…
Read More →
The pharmaceutical retailer AvKARE has published a voluntary recall notice for five different types of eye drops previously available through…
Read More →
When does the statute of repose clock start ticking on a product liability claim involving long-term repeat use of many…
Read More →
The first known lawsuit has now been filed against the makers of Dupixent (dupilumab), alleging that the popular eczema and…
Read More →
Cutaneous T-cell lymphoma (CTCL) is a rare and aggressive form of cancer that has been linked to the drug Dupixent…
Read More →
The following article was produced for and first presented at the 11th International Society of Construction Law Conference, 22-24 October…
Read More →
The holidays are upon us, and the last thing retailers want to do is respond to a security incident. Close…
Read More →
In the aftermath of a cyberattack, forensic investigations are often launched under intense pressure to identify what went wrong, why,…
Read More →
The United Kingdom’s National Cyber Security Centre (NCSC) has released its Annual Review for 2025. As in 2024, the report…
Read More →
Starting January 1, 2026, the California’s Transparency in Frontier Artificial Intelligence Act (“TFAIA”) introduces new requirements for developers of advanced…
Read More →